发明名称 Protein kinase inhibitors for treatment of neurological disorders
摘要 The invention features novel derivatives of K-252a e.g. (II-4) as well as novel bis-N-substituted derivatives of staurosporine of Formula (I). The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a. In the formula (I): ÄStauÜ - N(CH3)-W-N(CH3)-ÄStauÜ, ÄStauÜ represents a residue of formula (a) and W represents a radical of the formula: -C(=Y)-NH-W'-NH-C(=Y)- where W' is a hydrocarbylene radical of 2-20 carbon atoms and Y is O or S. In formula (II-4) R<1>, R<2>, Z<1> and Z<2> are each H; X is CH2OH; and R is OCH3.
申请公布号 EP1125938(A1) 申请公布日期 2001.08.22
申请号 EP20010110483 申请日期 1995.10.04
申请人 CEPHALON, INC.;KYOWA HAKKO KOGYO CO., LTD. 发明人 LEWIS, MICHAEL E.;KAUER, JAMES C;NEFF, NICOLA;ROBERTS-LEWIS, JILL;GLICKSMAN, MARCIE;MURAKATA, CHIKARA;SAITO, HIROMITSU;MATSUDA, YUZURU;KANAI, FUMIHIKO;KANEKO, MASAMI
分类号 A61K31/40;A61K31/407;A61K31/41;A61K31/415;A61K31/44;A61K31/505;A61K31/5377;A61K31/553;A61K31/7056;A61K38/22;A61P9/00;A61P9/10;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P31/18;C07D487/14;C07D498/22;C07D519/00 主分类号 A61K31/40
代理机构 代理人
主权项
地址